Journal of Movement Disorders

Volume 13(1); January 2020

Review Articles

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions: Masahito Yamada, Junji Komatsu, Keiko Nakamura, Kenji Sakai, Miharu Samuraki-Yokohama, Kenichi Nakajima, Mitsuhiro Yoshita; J Mov Disord. 2020;13(1):1-10. Published online November 8, 2019; DOI: https://doi.org/10.14802/jmd.19052

22,797 View
1,563 Download
24 Citations

The aim of this article is to describe the 2017 revised consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic criteria. The criteria for the clinical diagnosis of probable and possible DLB were first published as the first consensus report in 1996 and were revised in the third consensus report in 2005. After discussion at the International DLB Conference in Fort Lauderdale, Florida, USA, in 2015, the International DLB Consortium published the fourth consensus report including the revised consensus criteria in 2017. The 2017 revised criteria clearly distinguish between clinical features and diagnostic biomarkers. Significant new information about previously reported aspects of DLB has been incorporated, with increased diagnostic weighting given to rapid eye movement (REM) sleep behavior disorder (RBD) and iodine-123-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. Future directions include the development of the criteria for early diagnosis (prodromal DLB) and the establishment of new biomarkers that directly indicate Lewy-related pathology, including α-synuclein imaging, biopsies of peripheral tissues (skin, etc.) for the demonstration of α-synuclein deposition, and biochemical markers (cerebrospinal fluid/blood), as well as the pathological evaluation of the sensitivity and specificity of the 2017 revised diagnostic criteria. In conclusion, the revised consensus criteria for the clinical diagnosis of DLB were reported with the incorporation of new information about DLB in 2017. Future directions include the development of the criteria for early diagnosis and the establishment of biomarkers directly indicative of Lewy-related pathology.

Citations

Citations to this article as recorded by

Parkinson's disease fluid biomarkers for differential diagnosis of atypical parkinsonian syndromes
Jun Yang, Ayotimofe Idowu, Liana Rosenthal, Xiaobo Mao
Clinical and Translational Discovery.2023;[Epub] CrossRef
Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia
Irene Frigerio, Max A. Laansma, Chen-Pei Lin, Emma J. M. Hermans, Maud M. A. Bouwman, John G. J. M. Bol, Yvon Galis-de Graaf, Dagmar H. Hepp, Annemieke J. M. Rozemuller, Frederik Barkhof, Wilma D. J. van de Berg, Laura E. Jonkman
Translational Neurodegeneration.2023;[Epub] CrossRef
Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio
Koichi Okuda, Kenichi Nakajima, Chiemi Kitamura, Michael Ljungberg, Tetsuo Hosoya, Yumiko Kirihara, Mitsumasa Hashimoto
Journal of Nuclear Cardiology.2023;[Epub] CrossRef
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer’s Disease
Carolyn W. Zhu, Yian Gu, Anton J. Kociolek, Kayri K. Fernandez, Stephanie Cosentino, Yaakov Stern
Journal of Alzheimer's Disease.2023; 92(2): 457. CrossRef
Early- and late-onset of isolated rapid eye movement sleep behavior disorder: A retrospective cohort study
Li Zhou, Bei Huang, Jing Wang, Steven WH. Chau, Joey WY. Chan, Jihui Zhang, Mandy WM. Yu, Jessie CC. Tsang, Shirley Xin Li, Vincent CT. Mok, Yun Kwok Wing, Yaping Liu
Sleep Medicine.2023;[Epub] CrossRef
Parkinson Disease Dementia Management: an Update of Current Evidence and Future Directions
Oliver Phillips, Debolina Ghosh, Hubert H. Fernandez
Current Treatment Options in Neurology.2023; 25(5): 93. CrossRef
Rapidly progressive dementia with severe insomnia: an unusual case of progressive supranuclear palsy mimicking dementia with Lewy bodies
Rae On Kim, Eun Ji Lee, Seong-Ik Kim, Sung-Hye Park, Kyum-Yil Kwon
Neurological Sciences.2023;[Epub] CrossRef
Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes
Nils Schröter, Thilo van Eimeren, Joseph Classen, Johannes Levin, Christoph Redecker, Martin Wolz, Lars Tönges
Journal of Neural Transmission.2023; 130(6): 839. CrossRef
Electroencephalography in young onset dementia
Casey W Brown, Huei-Yang Chen, Peter K Panegyres
BMC Neurology.2023;[Epub] CrossRef
Autonomic symptoms are predictive of dementia with Lewy bodies
Wenzheng Hu, Shuai Liu, Fei Wang, Han Zhu, Xiaoshan Du, Lingyun Ma, Jinghuan Gan, Hao Wu, Xiaodan Wang, Yong Ji
Parkinsonism & Related Disorders.2022; 95: 1. CrossRef
Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?
Daniele Urso, Valentina Gnoni, Marco Filardi, Giancarlo Logroscino
Frontiers in Psychiatry.2022;[Epub] CrossRef
Clinical Trajectories at the End of Life in Autopsy-Confirmed Dementia Patients With Alzheimer Disease and Lewy Bodies Pathologies
Yian Gu, Anton Kociolek, Kayri K. Fernandez, Stephanie A. Cosentino, Carolyn Wei Zhu, Zhezhen Jin, James B. Leverenz, Yaakov B. Stern
Neurology.2022; 98(21): e2140. CrossRef
Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of 18F-FP-CIT PET/CT
Miju Cheon, Seung Min Kim, Sang-Won Ha, Min Ju Kang, Hea-Eun Yang, Jang Yoo
Diagnostics.2022; 12(6): 1402. CrossRef
The promise of amplification assays for accurate early detection of α-synucleinopathies: A review
Regina Kurapova, Leonidas Chouliaras, John T. O'Brien
Experimental Gerontology.2022; 165: 111842. CrossRef
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder
Annette Janzen, David Vadasz, Jan Booij, Markus Luster, Damiano Librizzi, Martin T. Henrich, Lars Timmermann, Mahboubeh Habibi, Elisabeth Sittig, Geert Mayer, Fanni Geibl, Wolfgang Oertel
Journal of Parkinson's Disease.2022; 12(6): 1921. CrossRef
A Systematic Review and Comparison of Neurocognitive Features of Late-Life Attention-Deficit/Hyperactivity Disorder and Dementia With Lewy Bodies
Jennifer L. Prentice, Morgan J. Schaeffer, Alexandra K. Wall, Brandy L. Callahan
Journal of Geriatric Psychiatry and Neurology.2021; 34(5): 466. CrossRef
Dementia with Lewy bodies in first-generation immigrants in a European memory clinic
Kurt Segers, Florence Benoit, Jean-Marie Meyts, Gérald Glibert, Sophie Levy, Murielle Surquin
Acta Neurologica Belgica.2021; 121(1): 219. CrossRef
The development of new method to differentiate between Dementia with Lewy bodies and Alzheimer’s disease by cerebral perfusion SPECT-comparison to CIScore
Gaku Honda, Shigeki Nagamachi, Masanari Nonokuma, Koichi Takano, Yasuo Kuwabara, Kengo Yoshimitsu, Hitoshi Iida, Koji Ogomori, Hiroaki Kawasaki, Yoshio Tsuboi
Japanese Journal of Radiology.2021; 39(2): 198. CrossRef
Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease
Xue-Bing Ding, Xin-Xin Wang, Dan-Hao Xia, Han Liu, Hai-Yan Tian, Yu Fu, Yong-Kang Chen, Chi Qin, Jiu-Qi Wang, Zhi Xiang, Zhong-Xian Zhang, Qin-Chen Cao, Wei Wang, Jia-Yi Li, Erxi Wu, Bei-Sha Tang, Ming-Ming Ma, Jun-Fang Teng, Xue-Jing Wang
Nature Medicine.2021; 27(3): 411. CrossRef
Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
Dariusz Koziorowski, Monika Figura, Łukasz M. Milanowski, Stanisław Szlufik, Piotr Alster, Natalia Madetko, Andrzej Friedman
Cells.2021; 10(3): 656. CrossRef
Advances in computerized MRI‐based biomarkers in Alzheimer’s disease
Raymond Wong, Yishan Luo, Vincent Chung-tong Mok, Lin Shi
Brain Science Advances.2021; 7(1): 26. CrossRef
Convolutional neural network-based automatic heart segmentation and quantitation in 123I-metaiodobenzylguanidine SPECT imaging
Shintaro Saito, Kenichi Nakajima, Lars Edenbrandt, Olof Enqvist, Johannes Ulén, Seigo Kinuya
EJNMMI Research.2021;[Epub] CrossRef
A direct comparison of the 2005 and 2017 criteria for dementia with Lewy bodies
Kurt Segers, Florence Benoit, Jean‐Marie Meyts, Gerald Glibert, Murielle Surquin
Psychogeriatrics.2020; 20(5): 785. CrossRef
Calibrated scintigraphic imaging procedures improve quantitative assessment of the cardiac sympathetic nerve activity
Koichi Okuda, Kenichi Nakajima, Chiemi Kitamura, Yumiko Kirihara, Mitsumasa Hashimoto, Seigo Kinuya
Scientific Reports.2020;[Epub] CrossRef

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies: Junghwan Shin, Han-Joon Kim, Beomseok Jeon; J Mov Disord. 2020;13(1):11-19. Published online December 19, 2019; DOI: https://doi.org/10.14802/jmd.19057

7,609 View
410 Download
17 Citations

Abstract PDF

α-Synuclein and tau deposition in the central nervous system is responsible for various parkinsonian syndromes, including Parkinson’s disease, multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Emerging evidence has suggested that pathologic α-synuclein and tau are transmitted from cell to cell and further accelerate the aggregation of pathologic proteins in neighboring cells. Furthermore, extracellular pathologic proteins have also been reported to provoke inflammatory responses that lead to neurodegeneration. Therefore, immunotherapies targeting extracellular α-synuclein and tau have been proposed as potential disease-modifying strategies. In this review, we summarize completed phase I trials and ongoing phase II trials of immunotherapies against α-synuclein and tau and further discuss concerns and hurdles to overcome in the future.

Citations

Citations to this article as recorded by

Modeling the dynamics of innate and adaptive immune response to Parkinson's disease with immunotherapy
Salma M. Al-Tuwairqi, Asma A. Badrah
AIMS Mathematics.2023; 8(1): 1800. CrossRef
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy
Winston T. Chu, Jesse Hall, Anjela Gurrala, Alexander Becsey, Shreya Raman, Michael S. Okun, Catherine T. Flores, Benoit I. Giasson, David E. Vaillancourt, Vinata Vedam-Mai
ACS Chemical Neuroscience.2023; 14(2): 235. CrossRef
Direct digital sensing of protein biomarkers in solution
Georg Krainer, Kadi L. Saar, William E. Arter, Timothy J. Welsh, Magdalena A. Czekalska, Raphaël P. B. Jacquat, Quentin Peter, Walther C. Traberg, Arvind Pujari, Akhila K. Jayaram, Pavankumar Challa, Christopher G. Taylor, Lize-Mari van der Linden, Titus
Nature Communications.2023;[Epub] CrossRef
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
Jacqui T. Nimmo, Harry Smith, Chang Yi Wang, Jessica L. Teeling, James A. R. Nicoll, Ajay Verma, Jean-Cosme Dodart, Zhi Liu, Feng Lin, Roxana O. Carare
Acta Neuropathologica.2022; 143(1): 55. CrossRef
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
Changyoun Kim, Armine Hovakimyan, Karen Zagorski, Tatevik Antonyan, Irina Petrushina, Hayk Davtyan, Gor Chailyan, Jonathan Hasselmann, Michiyo Iba, Anthony Adame, Edward Rockenstein, Marcell Szabo, Mathew Blurton-Jones, David H. Cribbs, Anahit Ghochikyan,
npj Vaccines.2022;[Epub] CrossRef
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim
Journal of Movement Disorders.2022; 15(1): 1. CrossRef
Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
Dhanya Vijayakumar, Joseph Jankovic
CNS Drugs.2022; 36(4): 327. CrossRef
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology.2022; 214: 102270. CrossRef
Modeling the dynamics of innate immune response to Parkinson disease with therapeutic approach
Asma Badrah, Salma Al-Tuwairqi
Physical Biology.2022; 19(5): 056004. CrossRef
Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease
Le Zhao, Dan Li, Xiaofen Qi, Kaifang Guan, Haoran Chen, Rongchun Wang, Ying Ma
Food & Function.2022; 13(21): 10851. CrossRef
Harnessing the immune system for the treatment of Parkinson’s disease
Vinata Vedam-Mai
Brain Research.2021; 1758: 147308. CrossRef
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Katja Badanjak, Sonja Fixemer, Semra Smajić, Alexander Skupin, Anne Grünewald
International Journal of Molecular Sciences.2021; 22(9): 4676. CrossRef
Viral alpha-synuclein knockdown prevents spreading synucleinopathy
Sindhu Menon, Rikke H Kofoed, Fadl Nabbouh, Kristiana Xhima, Yasmeen Al-Fahoum, Tammy Langman, Howard T J Mount, Lamya S Shihabuddin, S Pablo Sardi, Paul E Fraser, Joel C Watts, Isabelle Aubert, Anurag Tandon
Brain Communications.2021;[Epub] CrossRef
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Somin Kwon, Michiyo Iba, Changyoun Kim, Eliezer Masliah
Neurotherapeutics.2020; 17(3): 935. CrossRef
The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
Kyu-Young Sim, Kyeong Chan Im, Sung-Gyoo Park
International Journal of Molecular Sciences.2020; 21(15): 5295. CrossRef
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
Alzheimer's Research & Therapy.2020;[Epub] CrossRef
New Insights Into Drug Discovery Targeting Tau Protein
Yoshiyuki Soeda, Akihiko Takashima
Frontiers in Molecular Neuroscience.2020;[Epub] CrossRef

Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia: Shoichiro Ando, Masato Kanazawa, Osamu Onodera; J Mov Disord. 2020;13(1):20-26. Published online December 19, 2019; DOI: https://doi.org/10.14802/jmd.19061

8,104 View
389 Download
14 Citations

Abstract PDF

Progressive supranuclear palsy (PSP) is characterized by supranuclear gaze palsy, dystonic rigidity of the neck and upper trunk, frequent falls and mild cognitive impairment. Cerebellar ataxia is one of the exclusion criteria given by the National Institute of Neurological Disorders and Stroke and the Society for Progressive Supranuclear Palsy. As a result, pathologically proven PSP patients exhibiting cerebellar ataxia have often been misdiagnosed with spinocerebellar degeneration, specifically multiple system atrophy with predominant cerebellar ataxia (MSA-C). However, more recently, it has been recognized that patients with PSP can present with truncal and limb ataxia as their initial symptom and/or main manifestation. These patients can be classified as having PSP with predominant cerebellar ataxia (PSP-C), a new subtype of PSP. Since the development of this classification, patients with PSP-C have been identified primarily in Asian countries, and it has been noted that this condition is very rare in Western communities. Furthermore, the clinical features of PSP-C have been identified, enabling it to be distinguished from other subtypes of PSP and MSA-C. In this review, we describe the clinical and neuropathological features of PSP-C. The hypothesized pathophysiology of cerebellar ataxia in PSP-C is also discussed.

Citations

Citations to this article as recorded by

The Role of the Cerebellum in Swallowing
Ayodele Sasegbon, Shaheen Hamdy
Dysphagia.2023; 38(2): 497. CrossRef
Ataxias: Hereditary, Acquired, and Reversible Etiologies
Chi-Ying R. Lin, Sheng-Han Kuo
Seminars in Neurology.2023; 43(01): 048. CrossRef
Deciphering the saccade velocity profile of progressive supranuclear palsy: A sign of latent cerebellar/brainstem dysfunction?
Yasuo Terao, Shin-ichi Tokushige, Satomi Inomata-Terada, Hideki Fukuda, Akihiro Yugeta, Yoshikazu Ugawa
Clinical Neurophysiology.2022; 141: 147. CrossRef
Parkinsonism and ataxia
Giulia Franco, Giulia Lazzeri, Alessio Di Fonzo
Journal of the Neurological Sciences.2022; 433: 120020. CrossRef
Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
Patrycja Krzosek, Natalia Madetko, Anna Migda, Bartosz Migda, Dominika Jaguś, Piotr Alster
Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
Journal of Clinical Neurology.2022; 18(3): 259. CrossRef
Clinical Spectrum of Tauopathies
Nahid Olfati, Ali Shoeibi, Irene Litvan
Frontiers in Neurology.2022;[Epub] CrossRef
Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects
Jisoo Kim, Geoffrey S. Young, Andrew S. Willett, Ariana T. Pitaro, Grace F. Crotty, Merlyne Mesidor, Kristie A. Jones, Camden Bay, Min Zhang, Mel B. Feany, Xiaoyin Xu, Lei Qin, Vikram Khurana
The Cerebellum.2022;[Epub] CrossRef
Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future
Shane Lyons, Sean O'Dowd, Richard Walsh, Tim Lynch
Advances in Clinical Neuroscience & Rehabilitation.2022;[Epub] CrossRef
Cerebellar ataxia in progressive supranuclear palsy: a clinico-pathological case report
David Crosiers, Anne Sieben, Sarah Ceyssens, Paul M. Parizel, Jonathan Baets
Acta Neurologica Belgica.2021; 121(2): 599. CrossRef
Progressive supranuclear palsy
N.V. Fedorova, E.V. Bril, T.K. Kulua, A.D. Mikhaylova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2021; 121(5): 111. CrossRef
Case 20-2021: A 69-Year-Old Man with Ataxia
Richard C. Cabot, Eric S. Rosenberg, David M. Dudzinski, Meridale V. Baggett, Kathy M. Tran, Dennis C. Sgroi, Jo-Anne O. Shepard, Emily K. McDonald, Tara Corpuz, Vikram Khurana, Claudio M. de Gusmao, McKinley Glover, Jeffrey Helgager
New England Journal of Medicine.2021; 385(2): 165. CrossRef
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
Maria Stamelou, Gesine Respondek, Nikolaos Giagkou, Jennifer L. Whitwell, Gabor G. Kovacs, Günter U. Höglinger
Nature Reviews Neurology.2021; 17(10): 601. CrossRef
Tauopathy and Movement Disorders—Unveiling the Chameleons and Mimics
Jacky Ganguly, Mandar Jog
Frontiers in Neurology.2020;[Epub] CrossRef

Principles of Electrophysiological Assessments for Movement Disorders: Kai-Hsiang Stanley Chen, Robert Chen; J Mov Disord. 2020;13(1):27-38. Published online January 31, 2020; DOI: https://doi.org/10.14802/jmd.19064

11,995 View
999 Download
25 Citations

Abstract PDF Supplementary Material

Electrophysiological studies can provide objective and quantifiable assessments of movement disorders. They are useful in the diagnosis of hyperkinetic movement disorders, particularly tremors and myoclonus. The most commonly used measures are surface electromyography (sEMG), electroencephalography (EEG) and accelerometry. Frequency and coherence analyses of sEMG signals may reveal the nature of tremors and the source of the tremors. The effects of voluntary tapping, ballistic movements and weighting of the limbs can help to distinguish between organic and functional tremors. The presence of Bereitschafts-potentials and beta-band desynchronization recorded by EEG before movement onset provide strong evidence for functional movement disorders. EMG burst durations, distributions and muscle recruitment orders may identify and classify myoclonus to cortical, subcortical or spinal origins and help in the diagnosis of functional myoclonus. Organic and functional cervical dystonia can potentially be distinguished by EMG power spectral analysis. Several reflex circuits, such as the long latency reflex, blink reflex and startle reflex, can be elicited with different types of external stimuli and are useful in the assessment of myoclonus, excessive startle and stiff person syndrome. However, limitations of the tests should be recognized, and the results should be interpreted together with clinical observations.

Citations

Citations to this article as recorded by

Asterixis of peripheral origin: isolated lower limb asterixis in Guillain–Barre syndrome
Boby Varkey Maramattom
Acta Neurologica Belgica.2023; 123(3): 1095. CrossRef
Moving Beyond Movement: Diagnosing Functional Movement Disorder
Gabriela S. Gilmour, Sarah C. Lidstone
Seminars in Neurology.2023; 43(01): 106. CrossRef
The clinical and electrophysiological investigation of tremor
Günther Deuschl, Jos S. Becktepe, Michiel Dirkx, Dietrich Haubenberger, Anhar Hassan, Rick C. Helmich, Muthuraman Muthuraman, Pattamon Panyakaew, Petra Schwingenschuh, Kirsten E. Zeuner, Rodger J. Elble
Clinical Neurophysiology.2022; 136: 93. CrossRef
Remote measurement and home monitoring of tremor
Zoltan Mari, Dietrich Haubenberger
Journal of the Neurological Sciences.2022; 435: 120201. CrossRef
Functional tremor
Petra Schwingenschuh, Alberto J. Espay
Journal of the Neurological Sciences.2022; 435: 120208. CrossRef
Speech-induced action myoclonus
Hugh D. Simpson, Joseph R. Duffy, Julie A.G. Stierwalt, J. Eric Ahlskog, Anhar Hassan
Parkinsonism & Related Disorders.2022; 98: 41. CrossRef
Simulation of the physical process of neural electromagnetic signal generation based on a simple but functional bionic Na+ channel
Fan Wang, Jingjing Xu, Yanbin Ge, Shengyong Xu, Yanjun Fu, Caiyu Shi, Jianming Xue
Chinese Physics B.2022; 31(6): 068701. CrossRef
Functional Patients Referred for Deep Brain Stimulation: How Common Is it?
Carolina Gorodetsky, Paula Azevedo, Alfonso Fasano
Movement Disorders Clinical Practice.2022; 9(6): 841. CrossRef
Myoclonus and other jerky movement disorders
Sterre van der Veen, John N. Caviness, Yasmine E.M. Dreissen, Christos Ganos, Abubaker Ibrahim, Johannes H.T.M. Koelman, Ambra Stefani, Marina A.J. Tijssen
Clinical Neurophysiology Practice.2022; 7: 285. CrossRef
Posthypoxic Segmental Spinal “Flutter”-Like Myoclonus
BobyV Maramattom
Neurology India.2022; 70(5): 2202. CrossRef
Contemporary clinical neurophysiology applications in dystonia
Petr Kaňovský, Raymond Rosales, Pavel Otruba, Martin Nevrlý, Lenka Hvizdošová, Robert Opavský, Michaela Kaiserová, Pavel Hok, Kateřina Menšíková, Petr Hluštík, Martin Bareš
Journal of Neural Transmission.2021; 128(4): 509. CrossRef
Suggestibility as a valuable criterion for laboratory-supported definite functional movement disorders
Gerard Saranza, Daniel Vargas-Mendez, Anthony E. Lang, Robert Chen
Clinical Neurophysiology Practice.2021; 6: 103. CrossRef
Peribuccal and pharyngeal myorhythmia as a presenting symptom of hypertrophic olivary degeneration: Expert commentary
Robert Chen
Parkinsonism & Related Disorders.2021; 85: 144. CrossRef
Nano‐dielectrics in biosystems
Jingjing Xu, Fan Wang, Yihan Song, Song Ge, Shengyong Xu
IET Nanodielectrics.2021; 4(4): 179. CrossRef
Jaw Pain and Oromandibular Dysfunction After a Complex Hospital Course
Sarah Smith, Ny-Ying Lam
American Journal of Physical Medicine & Rehabilitation.2021; 100(5): e62. CrossRef
Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
Carolina Gorodetsky, Paula Azevedo, Carolina Candeias da Silva, Alfonso Fasano
Toxins.2021; 13(8): 511. CrossRef
Tremor Syndromes: An Updated Review
Abhishek Lenka, Joseph Jankovic
Frontiers in Neurology.2021;[Epub] CrossRef
The diagnostic value of clinical neurophysiology in hyperkinetic movement disorders: A systematic review
S. van der Veen, M.R. Klamer, J.W.J. Elting, J.H.T.M. Koelman, A.M.M. van der Stouwe, M.A.J. Tijssen
Parkinsonism & Related Disorders.2021; 89: 176. CrossRef
Wearable monitoring of positive and negative myoclonus in progressive myoclonic epilepsy type 1
Saara M. Rissanen, Jelena Hyppönen, Katri Silvennoinen, Laura Säisänen, Pasi A. Karjalainen, Esa Mervaala, Reetta Kälviäinen
Clinical Neurophysiology.2021; 132(10): 2464. CrossRef
Surface electromyography for evaluating patients with oromandibular dystonia
Jae-Hyung Kim, Byung-Gook Kim, Yeong-Gwan Im
CRANIO®.2021; : 1. CrossRef
Evaluation of movement and brain activity
Mark Hallett, Lourdes M. DelRosso, Rodger Elble, Raffaele Ferri, Fay B. Horak, Stephan Lehericy, Martina Mancini, Masao Matsuhashi, Riki Matsumoto, Muthuraman Muthuraman, Jan Raethjen, Hiroshi Shibasaki
Clinical Neurophysiology.2021; 132(10): 2608. CrossRef
Clinical and Psychological Aspects of Myoclonus in Different age Periods
Т.А. Литовченко, О.Ю. Сухоносова
Психиатрия, психотерапия и клиническая психология.2021; (2): 303. CrossRef
FEATURES OF EPILEPTIC MYOCLONIC SEIZURES IN PATIENTS AT DIFFERENT AGE PERIODS
T. A. Litovchenko, O. Yu. Sukhonosova, A. I. Ekzarkhova, S. M. Korenev, V. V. Salnikova, V. B. Olenich
International Medical Journal.2021; (4(108)): 61. CrossRef
Minimum Electromyographic Burst Duration in Healthy Controls: Implications for Electrodiagnosis in Movement Disorders
Alexis F. Collins, Steven T.R. Brown, Mark R. Baker
Movement Disorders Clinical Practice.2020; 7(7): 827. CrossRef
Physiology-Based Treatment of Myoclonus
Ashley B. Pena, John N. Caviness
Neurotherapeutics.2020; 17(4): 1665. CrossRef

Original Articles

Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes: Martina Bocchetta, Juan Eugenio Iglesias, Viorica Chelban, Edwin Jabbari, Ruth Lamb, Lucy L. Russell, Caroline V. Greaves, Mollie Neason, David M. Cash, David L. Thomas, Jason D. Warren, John Woodside, Henry Houlden, Huw R. Morris, Jonathan D. Rohrer; J Mov Disord. 2020;13(1):39-46. Published online September 26, 2019; DOI: https://doi.org/10.14802/jmd.19030

5,723 View
223 Download
14 Citations

Abstract PDF Supplementary Material

Objective
Brainstem segmentation has been useful in identifying potential imaging biomarkers for diagnosis and progression in atypical parkinsonian syndromes (APS). However, the majority of work has been performed using manual segmentation, which is time consuming for large cohorts.
Methods
We investigated brainstem involvement in APS using an automated method. We measured the volume of the medulla, pons, superior cerebellar peduncle (SCP) and midbrain from T1-weighted MRIs in 67 patients and 42 controls. Diagnoses were corticobasal syndrome (CBS, n = 14), multiple system atrophy (MSA, n = 16: 8 with parkinsonian syndrome, MSA-P; 8 with cerebellar syndrome, MSA-C), progressive supranuclear palsy with a Richardson’s syndrome (PSP-RS, n = 12), variant PSP (n = 18), and APS not otherwise specified (APS-NOS, n = 7).
Results
All brainstem regions were smaller in MSA-C (19–42% volume difference, p < 0.0005) and in both PSP groups (18–33%, p < 0.0005) than in controls. MSA-P showed lower volumes in all regions except the SCP (15–26%, p < 0.0005). The most affected region in MSA-C and MSA-P was the pons (42% and 26%, respectively), while the most affected regions in both the PSP-RS and variant PSP groups were the SCP (33% and 23%, respectively) and midbrain (26% and 24%, respectively). The brainstem was less affected in CBS, but nonetheless, the pons (14%, p < 0.0005), midbrain (14%, p < 0.0005) and medulla (10%, p = 0.001) were significantly smaller in CBS than in controls. The brainstem was unaffected in APS-NOS.
Conclusion
Automated methods can accurately quantify the involvement of brainstem structures in APS. This will be important in future trials with large patient numbers where manual segmentation is unfeasible.

Citations

Citations to this article as recorded by

Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study
Agnès Pérez-Millan, Sergi Borrego-Écija, John C. van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik
Journal of Neurology.2023; 270(3): 1573. CrossRef
Comparative validation of AI and non-AI methods in MRI volumetry to diagnose Parkinsonian syndromes
Joomee Song, Juyoung Hahm, Jisoo Lee, Chae Yeon Lim, Myung Jin Chung, Jinyoung Youn, Jin Whan Cho, Jong Hyeon Ahn, Kyungsu Kim
Scientific Reports.2023;[Epub] CrossRef
Identification of the pathogenesis features of various phenotypes of multiple sclerosis based on the study of the morphological functional connectivity of subcortical gray matter structures
A. G. Trufanov, A. Y. Polushin, E. A. Gorbunova, M. V. Lukin
Russian Journal for Personalized Medicine.2023; 3(1): 27. CrossRef
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort
Martina Bocchetta, Emily G Todd, Arabella Bouzigues, David M Cash, Jennifer M Nicholas, Rhian S Convery, Lucy L Russell, David L Thomas, Ian B Malone, Juan Eugenio Iglesias, John C van Swieten, Lize C Jiskoot, Harro Seelaar, Barbara Borroni, Daniela Galim
Brain Communications.2023;[Epub] CrossRef
Neuroimaging correlates of brain injury in Wilson’s disease: a multimodal, whole-brain MRI study
Samuel Shribman, Martina Bocchetta, Carole H Sudre, Julio Acosta-Cabronero, Maggie Burrows, Paul Cook, David L Thomas, Godfrey T Gillett, Emmanuel A Tsochatzis, Oliver Bandmann, Jonathan D Rohrer, Thomas T Warner
Brain.2022; 145(1): 263. CrossRef
Nuclear imaging in Parkinson's disease: The past, the present, and the future
Haim Golan, Olga Volkov, Eli Shalom
Journal of the Neurological Sciences.2022; 436: 120220. CrossRef
Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles
Minori Furuta, Masayuki Sato, Setsuki Tsukagoshi, Yoshito Tsushima, Yoshio Ikeda
Journal of the Neurological Sciences.2022; 438: 120281. CrossRef
A data-driven model of brain volume changes in progressive supranuclear palsy
W. J. Scotton, M. Bocchetta, E. Todd, D. M. Cash, N. Oxtoby, L. VandeVrede, H. Heuer, D. C. Alexander, J. B. Rowe, H. R. Morris, A. Boxer, J. D. Rohrer, P. A. Wijeratne
Brain Communications.2022;[Epub] CrossRef
Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease
Samuel Shribman, Maggie Burrows, Rhian Convery, Martina Bocchetta, Carole H. Sudre, Julio Acosta‐Cabronero, David L. Thomas, Godfrey T. Gillett, Emmanuel A. Tsochatzis, Oliver Bandmann, Jonathan D. Rohrer, Thomas T. Warner
Movement Disorders.2022; 37(8): 1728. CrossRef
Corticobasal syndrome and Parkinson’s disease at the beginning: asymmetrical patterns of MRI and Blink Reflex for early diagnosis
Giulia Donzuso, Giorgia Sciacca, Antonina Luca, Calogero E. Cicero, Giovanni Mostile, Alessandra Nicoletti, Mario Zappia
Journal of Neural Transmission.2022; 129(12): 1427. CrossRef
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy
Ji-Hyun Choi, Heejung Kim, Jung Hwan Shin, Jee-Young Lee, Han-Joon Kim, Jong-Min Kim, Beomseok Jeon
Journal of Neurology.2021; 268(3): 967. CrossRef
Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: Actuality and expectations
Annalisa Vitale, Rossella Villa, Lorenzo Ugga, Valeria Romeo, Arnaldo Stanzione, Renato Cuocolo
Mathematical Biosciences and Engineering.2021; 18(2): 1753. CrossRef
Differential early subcortical involvement in genetic FTD within the GENFI cohort
Martina Bocchetta, Emily G. Todd, Georgia Peakman, David M. Cash, Rhian S. Convery, Lucy L. Russell, David L. Thomas, Juan Eugenio Iglesias, John C. van Swieten, Lize C. Jiskoot, Harro Seelaar, Barbara Borroni, Daniela Galimberti, Raquel Sanchez-Valle, Ro
NeuroImage: Clinical.2021; 30: 102646. CrossRef
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes
Germain Arribarat, Patrice Péran
Current Opinion in Neurology.2020; 33(2): 222. CrossRef

Comparison of Spontaneous Motor Tempo during Finger Tapping, Toe Tapping and Stepping on the Spot in People with and without Parkinson’s Disease: Dawn Rose, Daniel J. Cameron, Peter J. Lovatt, Jessica A. Grahn, Lucy E. Annett; J Mov Disord. 2020;13(1):47-56. Published online January 31, 2020; DOI: https://doi.org/10.14802/jmd.19043

14,422 View
153 Download
11 Citations

Abstract PDF Supplementary Material

Objective
Spontaneous motor tempo (SMT), observed in walking, tapping and clapping, tends to occur around 2 Hz. Initiating and controlling movement can be difficult for people with Parkinson’s (PWP), but studies have not identified whether PWP differ from controls in SMT. For community-based interventions, e.g. dancing, it would be helpful to know a baseline SMT to optimize the tempi of cued activities. Therefore, this study compared finger tapping (FT), toe tapping (TT) and stepping ‘on the spot’ (SS) in PWP and two groups of healthy controls [age-matched controls (AMC) and young healthy controls (YHC)], as SMT is known to change with age.
Methods
Participants (PWP; n = 30, AMC; n = 23, YHC; n = 35) were asked to tap or step on the spot at a natural pace for two trials lasting 40 seconds. The central 30 seconds were averaged for analyses using mean inter-onset intervals (IOI) and coefficient of variation (CoV) to measure rate and variability respectively.
Results
PWP had faster SMT than both control groups, depending on the movement modality: FT, F(2, 87) = 7.92, p < 0.01 (PWP faster than YHC); TT, F(2, 87) = 4.89, p = 0.01 (PWP faster than AMC); and SS, F(2, 77) = 3.26, p = 0.04 (PWP faster than AMC). PWP had higher CoV (more variable tapping) than AMC in FT only, F(2, 87) = 4.10, p = 0.02.
Conclusion
This study provides the first direct comparison of SMT between PWP and two control groups for different types of movements. Results suggest SMT is generally faster in PWP than control groups, and more variable when measured with finger tapping compared to stepping on the spot.

Citations

Citations to this article as recorded by

Clinical utility of paced finger tapping assessment in idiopathic normal pressure hydrocephalus
Yoko Shimizu, Motoki Tanikawa, Mitsuya Horiba, Kento Sahashi, Shoji Kawashima, Akihiko Kandori, Tomoyasu Yamanaka, Yusuke Nishikawa, Noriyuki Matsukawa, Yoshino Ueki, Mitsuhito Mase
Frontiers in Human Neuroscience.2023;[Epub] CrossRef
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease
Manuel Bange, Gabriel Gonzalez-Escamilla, Tabea Marquardt, Angela Radetz, Christian Dresel, Damian Herz, Wolfgang Immanuel Schöllhorn, Sergiu Groppa, Muthuraman Muthuraman
Journal of Parkinson's Disease.2022; 12(1): 381. CrossRef
Memory-Paced Tapping to Auditory Rhythms: Effects of Rate, Speech, and Motor Engagement
Anat Kliger Amrani, Elana Zion Golumbic
Journal of Speech, Language, and Hearing Research.2022; 65(3): 923. CrossRef
Virtual Reality to Evaluate the Impact of Colorful Interventions and Nature Elements on Spontaneous Walking, Gaze, and Emotion
Adamantia Batistatou, Florentin Vandeville, Yvonne N. Delevoye-Turrell
Frontiers in Virtual Reality.2022;[Epub] CrossRef
Synchronization during Improvised Active Music Therapy in clients with Parkinson’s disease
Demian Kogutek, Emily Ready, Jeffrey D. Holmes, Jessica A. Grahn
Nordic Journal of Music Therapy.2022; : 1. CrossRef
Neural synchronization is strongest to the spectral flux of slow music and depends on familiarity and beat salience
Kristin Weineck, Olivia Xin Wen, Molly J Henry
eLife.2022;[Epub] CrossRef
Spontaneous motor tempo contributes to preferred music tempo regardless of music familiarity
Kyoko Hine, Koki Abe, Yuya Kinzuka, Mohammad Shehata, Katsunobu Hatano, Toshie Matsui, Shigeki Nakauchi
Frontiers in Psychology.2022;[Epub] CrossRef
A general procedure to measure the pacing of body movements timed to music and metronome in younger and older adults
Dawn Rose, Laurent Ott, Ségolène M. R. Guérin, Lucy E. Annett, Peter Lovatt, Yvonne N. Delevoye-Turrell
Scientific Reports.2021;[Epub] CrossRef
Synchronization and locking in oscillators with flexible periods
Mariya Savinov, David Swigon, Bard Ermentrout
Chaos: An Interdisciplinary Journal of Nonlinear Science.2021; 31(3): 033143. CrossRef
Hierarchical control as a shared neurocognitive mechanism for language and music
Rie Asano, Cedric Boeckx, Uwe Seifert
Cognition.2021; 216: 104847. CrossRef
Spontaneous and stimulus-driven rhythmic behaviors in ADHD adults and controls
Anat Kliger Amrani, Elana Zion Golumbic
Neuropsychologia.2020; 146: 107544. CrossRef

Brief communication

Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure: Juan Miguel Pilar Bautista, Genko Oyama, Maierdanjiang Nuermaimaiti, Satoko Sekimoto, Fuyuko Sasaki, Taku Hatano, Kenya Nishioka, Masanobu Ito, Atsushi Umemura, Yuji Ishibashi, Yasushi Shimo, Nobutaka Hattori; J Mov Disord. 2020;13(1):57-61. Published online January 31, 2020; DOI: https://doi.org/10.14802/jmd.19051

5,042 View
148 Download
5 Citations

Abstract PDF

Objective
The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson’s disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple adjustments of DBS settings and medications.
Methods
We conducted a retrospective chart review of three patients for whom levodopa-carbidopa intestinal gel (LCIG) was additionally administered as a rescue therapy for secondary DBS failure due to the recurrence of motor fluctuations.
Results
The three patients had advanced PD with a disease duration of 14–19 years, and had undergone DBS for motor fluctuations refractory to standard medical management. LCIG was administered to the patients because of symptom recurrence years after DBS and provided complementary effects in all patients.
Conclusion
The cases presented here show that rescue LCIG therapy may be a complementary treatment option for patients with post-DBS advanced PD who have a recurrence of troublesome motor complications.

Citations

Citations to this article as recorded by

Combining Device‐Aided Therapies in Parkinson's Disease: A Case Series and a Literature Review
Iro Boura, Nikolaos Haliasos, Ιrene‐Areti Giannopoulou, Dimitrios Karabetsos, Cleanthe Spanaki
Movement Disorders Clinical Practice.2021; 8(5): 750. CrossRef
Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
Daniël van Poppelen, Annelie N.M. Tromp, Rob M.A. de Bie, Joke M. Dijk
Journal of Personalized Medicine.2021; 11(6): 547. CrossRef
Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
Valentina Leta, Haidar S. Dafsari, Anna Sauerbier, Vinod Metta, Nataliya Titova, Lars Timmermann, Keyoumars Ashkan, Michael Samuel, Eero Pekkonen, Per Odin, Angelo Antonini, Pablo Martinez-Martin, Miriam Parry, Daniel J. van Wamelen, K. Ray Chaudhuri
Journal of Personalized Medicine.2021; 11(8): 773. CrossRef
Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
Yassine Noui, Monty Adam Silverdale, Julian Evans, Lucy Partington-Smith, Christopher Kobylecki
Journal of Movement Disorders.2021; 14(3): 239. CrossRef
The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?
Joke M. Dijk, Alberto J. Espay, Regina Katzenschlager, Rob M.A. de Bie, Bastiaan R. Bloem, Patrik Brundin
Journal of Parkinson's Disease.2020; 10(s1): S65. CrossRef

Case Report

A Case of Abnormal Postures in the Left Extremities after Pontine Hemorrhage: Dystonia or Pseudodystonia?: Chan Wook Park, Seok Jong Chung, Young H. Sohn, Phil Hyu Lee; J Mov Disord. 2020;13(1):62-65. Published online January 31, 2020; DOI: https://doi.org/10.14802/jmd.19074

4,203 View
122 Download
1 Citations

Abstract PDF Supplementary Material

It is difficult to determine the pathoanatomical correlates of dystonia because of its complex pathophysiology, and most cases with secondary dystonia are associated with basal ganglia lesions. Moreover, it is a challenging issue that patients with abnormal postures accompanied by other neurological findings in the affected body part (e.g., sensory loss) can be diagnosed with true dystonia or pseudodystonia. Here, we report a case of abnormal postures with loss of proprioception in the left extremities after right dorsal pontine hemorrhage.

Citations

Citations to this article as recorded by

Hemidystonia after Pontine Hemorrhage Successfully Treated with Pharmacotherapy and Intensive Rehabilitation: a Case Report
Gyu Seong Kim, Yeon Gyu Jeong, Yoon Jeong Jeong, Seo Yeon Yoon
Brain & Neurorehabilitation.2021;[Epub] CrossRef

Letters to the editor

A Patient with Neuroferritinopathy Presenting with Juvenile-Onset Voice Tremor: Chan Wook Park, Nan Young Kim, Yun Joong Kim, Sook Keun Song, Chul Hyoung Lyoo; J Mov Disord. 2020;13(1):66-68. Published online August 9, 2019; DOI: https://doi.org/10.14802/jmd.19038

5,946 View
97 Download
3 Citations

PDF

Citations

Citations to this article as recorded by

Cerebral Iron Deposition in Neurodegeneration
Petr Dusek, Tim Hofer, Jan Alexander, Per M. Roos, Jan O. Aaseth
Biomolecules.2022; 12(5): 714. CrossRef
Pathogenic mechanism and modeling of neuroferritinopathy
Anna Cozzi, Paolo Santambrogio, Maddalena Ripamonti, Ermanna Rovida, Sonia Levi
Cellular and Molecular Life Sciences.2021; 78(7): 3355. CrossRef
Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation
Jae-Hyeok Lee, Ji Young Yun, Allison Gregory, Penelope Hogarth, Susan J. Hayflick
Frontiers in Neurology.2020;[Epub] CrossRef

Unilateral Pseudo-Orthostatic Tremor Provoked by a Remote Limb Movement in Parkinson’s Disease: Sang-Won Yoo, Youngje Heo, Joong-Seok Kim, Kwang-Soo Lee; J Mov Disord. 2020;13(1):69-71. Published online November 8, 2019; DOI: https://doi.org/10.14802/jmd.19056

4,515 View
96 Download
1 Citations

PDF Supplementary Material

Citations

Citations to this article as recorded by

Tremor Syndromes: An Updated Review
Abhishek Lenka, Joseph Jankovic
Frontiers in Neurology.2021;[Epub] CrossRef

Combined Hemichorea and Seizures in a Patient with Nonketotic Hyperglycemia: Ryul Kim, Hee-Jin Cho, Ho-Won Lee, Jin-Sun Jun; J Mov Disord. 2020;13(1):72-73. Published online November 8, 2019; DOI: https://doi.org/10.14802/jmd.19058

4,918 View
127 Download
4 Citations

PDF Supplementary Material

Citations

Citations to this article as recorded by

Oxidative stress: a common imbalance in diabetes and epilepsy
Karen Paola Ramos-Riera, Francisca Pérez-Severiano, María Leonor López-Meraz
Metabolic Brain Disease.2023; 38(3): 767. CrossRef
Recurrent Facial Focal Seizures With Chronic Striatopathy and Caudate Atrophy—A Double Whammy in an Elderly Woman With Diabetes Mellitus
Subhankar Chatterjee, Ritwik Ghosh, Umesh Kumar Ojha, Diksha, Payel Biswas, Julián Benito-León, Souvik Dubey
The Neurohospitalist.2022; 12(1): 147. CrossRef
Is diabetic striatopathy the culprit of seizures in a patient with ketotic hyperglycemia-induced hemichorea–hemiballismus?
Abeer Sabry Safan, Omna Sharma, Muna Almasri, Ashton Ian D’Souza, Omer Suliman
BMC Neurology.2022;[Epub] CrossRef
Bilateral striatum with high-signal intensity on T1-weighted MRI: A case of hemichorea induced by nonketotic hyperglycemia
Yuanyi Pan, Fattyang Chew, Rongping Wang, Xuntao Yin, Yaying Li
Radiology Case Reports.2021; 16(4): 895. CrossRef

Brainstem-Predominant Lewy-Related Pathology in a Patient with Parkinson’s Disease without Dementia: Ji-Hyun Choi, Sung-Hye Park, Sung Sup Park, Beomseok Jeon; J Mov Disord. 2020;13(1):74-76. Published online December 19, 2019; DOI: https://doi.org/10.14802/jmd.19059

4,079 View
96 Download
2 Citations

PDF Supplementary Material

Citations

Citations to this article as recorded by

Morphological differences between the two major subtypes of multiple system atrophy with cognitive impairment
Kurt A. Jellinger
Parkinsonism & Related Disorders.2023; 107: 105273. CrossRef
Neuropathological findings in multiple system atrophy with cognitive impairment
Kurt A. Jellinger
Journal of Neural Transmission.2020; 127(7): 1031. CrossRef

Erratum

Modeling α-Synuclein Propagation with Preformed Fibril Injections: Hyun Kyung Chung, Hoang-Anh Ho, Dayana Pérez-Acuña, Seung-Jae Lee; J Mov Disord. 2020;13(1):77-79. Published online October 14, 2019; DOI: https://doi.org/10.14802/jmd.19046.e; Corrects: J Mov Disord 2019;12(3):139

4,392 View
116 Download
7 Citations

PDF

Citations

Citations to this article as recorded by

Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
Shenjie Wu, Nancy C Hernandez Villegas, Daniel W Sirkis, Iona Thomas-Wright, Richard Wade-Martins, Randy Schekman
eLife.2023;[Epub] CrossRef
Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease
Rui Huang, Yuyuan Gao, Qingrui Duan, Qingxi Zhang, Peikun He, Jianing Chen, Guixian Ma, Limin Wang, Yuhu Zhang, Kun Nie, Lijuan Wang
Molecular Neurobiology.2023; 60(2): 979. CrossRef
Impaired dopamine release in Parkinson’s disease
Kaitlyn M L Cramb, Dayne Beccano-Kelly, Stephanie J Cragg, Richard Wade-Martins
Brain.2023;[Epub] CrossRef
Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets
Smrithi Padmakumar, Praveen Kulkarni, Craig F. Ferris, Benjamin S. Bleier, Mansoor M. Amiji
Biomedicine & Pharmacotherapy.2022; 149: 112812. CrossRef
Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
Rodrigo Tomas-Grau, Florencia González-Lizárraga, Diego Ploper, César L. Avila, Sergio B. Socías, Pierre Besnault, Aurore Tourville, Rosa M. Mella, Patricia Villacé, Clarisa Salado, Clémence Rose, Blandine Seon-Méniel, Jean-Michel Brunel, Laurent Ferrié,
Cells.2022; 11(17): 2759. CrossRef
Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
Renee C Gentzel, Dawn Toolan, Sarah Jinn, Joel B Schachter, Lei Ma, Philipp J Kahle, Sean M Smith, Jacob N Marcus
Neurobiology of Aging.2021; 106: 12. CrossRef
Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
Alix Booms, Gerhard A. Coetzee
Frontiers in Cellular Neuroscience.2021;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Previous issues